CodeMap® Compliance Briefing: March 12, 2015
Diagnostic manufacturers continually develop new and clinically useful point of care tests that are classified by CLIA as waived. So many of these tests enter the market each year that the federal agencies responsible for their classification and coding sometimes have trouble keeping up with the significant number of submissions. This week, we will discuss CLIA waived tests, how providers should code them, and recent developments concerning newly classified procedures. We will also examine the interaction between two federal agencies, the FDA and CMS, that result in the classification and subsequent payment by Medicare for these waived procedures. As always, please forward any questions, comments, or suggestions via email.
Sorry, the full document you are trying to access requires an active subscription.
Please login to the left.